Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Gastrointestinal and Liver Diseases : JGLD|February 6, 2021
Six-Minute Walking Test as a Predictor of Clinical Decompensation in Patients with CirrhosisDiane Michela Nery Henrique, Carla Malaguti, Tuany Mangeste Limonge, et al.
Biomed Research International|February 24, 2015
Anemia in inflammatory bowel disease outpatients: prevalence, risk factors, and etiologyCarla Valéria de Alvarenga Antunes, Abrahão Elias Hallack Neto, Cristiano Rodrigo de Alvarenga Nascimento, et al.
Biomed Research International|June 20, 2015
Physical Activity in Hemodialysis Patients Measured by Triaxial AccelerometerEdimar Pedrosa Gomes, Maycon Moura Reboredo, Erich Vidal Carvalho, et al.
Revista Da Associacao Medica Brasileira (1992)|July 24, 2024
Metabolic dysfunction-associated steatotic liver disease prevalence and risk factors in inflammatory bowel disease in tertiary centerLívia Dos Remédios Pamplona de Oliveira, Tarsila Campanha da Rocha Ribeiro, Carlos Alberto Mourao Junior, et al.
Biomedicines|June 28, 2023
Efficacy of Early Optimization of Infliximab Guided by Therapeutic Drug Monitoring during Induction-A Prospective TrialKaroline Soares Garcia, Matheus Freitas Cardoso de Azevedo, Alexandre de Sousa Carlos, et al.
Crohn'S & Colitis 360|April 29, 2024
Effectiveness and Safety of Ustekinumab for Ulcerative Colitis: A Brazilian Multicentric Observational StudyRogério Serafim Parra, Júlio Maria Fonseca Chebli, Matheus Freitas Cardoso de Azevedo, et al.
BMC Gastroenterology|April 22, 2022
Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn's disease: a real-world multicenter Brazilian studyRogério Serafim Parra, Júlio Maria Fonseca Chebli, Natália Sousa Freitas Queiroz, et al.
Gastroenterologia Y Hepatologia|February 23, 2025
Clinical effectiveness and safety of vedolizumab versus infliximab in biologic-naïve patients with ulcerative colitis: A comparative real-world multicentric observational studySandro da Costa Ferreira, Rogério Serafim Parra, Ligia Yukie Sassaki, et al.
BMC Gastroenterology|March 19, 2025
Tofacitinib for ulcerative colitis in Brazil: a multicenter observational study on effectiveness and safetyRogério Serafim Parra, Renata de Sá Brito Fróes, Daniela Oliveira Magro, et al.
Arquivos De Gastroenterologia|March 30, 2023
SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF ULCERATIVE COLITIS IN ADULTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB)Júlio Pinheiro Baima, Marcello Imbrizi, Adriana Ribas Andrade, et al.
Pageof 4